AU Patent

AU2015202356B2 — Amantadine compositions and methods of use

Assigned to Adamas Pharma LLC · Expires 2017-02-23 · 9y expired

What this patent protects

AMANTADINE COMPOSITIONS AND METHODS OF USE Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administ…

USPTO Abstract

AMANTADINE COMPOSITIONS AND METHODS OF USE Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015202356B2
Jurisdiction
AU
Classification
Expires
2017-02-23
Drug substance claim
No
Drug product claim
No
Assignee
Adamas Pharma LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.